Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 279

1.

Author Correction: Acromegaly.

Colao A, Grasso LFS, Giustina A, Melmed S, Chanson P, Pereira AM, Pivonello R.

Nat Rev Dis Primers. 2019 Oct 21;5(1):72. doi: 10.1038/s41572-019-0129-5.

PMID:
31636262
2.

Pituitary magnetic resonance imaging predictive role in the therapeutic response of growth hormone-secreting pituitary adenomas.

Tortora F, Negro A, Grasso LFS, Colao A, Pivonello R, Splendiani A, Brunese L, Caranci F.

Gland Surg. 2019 Sep;8(Suppl 3):S150-S158. doi: 10.21037/gs.2019.06.04.

3.

Assessment of serum thyroid hormone autoantibodies in the first trimester of gestation as predictors of postpartum thyroiditis.

Benvenga S, Vita R, Di Bari F, Lo Re C, Scilipoti A, Giorgianni G, Grasso L, Galletti MR, Mandolfino MG, Le Donne M.

J Clin Transl Endocrinol. 2019 Jul 24;18:100201. doi: 10.1016/j.jcte.2019.100201. eCollection 2019 Dec.

4.

Acromegaly and Heart Failure.

Colao A, Grasso LFS, Di Somma C, Pivonello R.

Heart Fail Clin. 2019 Jul;15(3):399-408. doi: 10.1016/j.hfc.2019.03.001. Review.

PMID:
31079698
5.

Acromegaly.

Colao A, Grasso LFS, Giustina A, Melmed S, Chanson P, Pereira AM, Pivonello R.

Nat Rev Dis Primers. 2019 Mar 21;5(1):20. doi: 10.1038/s41572-019-0071-6. Review. Erratum in: Nat Rev Dis Primers. 2019 Oct 21;5(1):72.

PMID:
30899019
6.

RNase H activities counteract a toxic effect of Polymerase η in cells replicating with depleted dNTP pools.

Meroni A, Nava GM, Bianco E, Grasso L, Galati E, Bosio MC, Delmastro D, Muzi-Falconi M, Lazzaro F.

Nucleic Acids Res. 2019 May 21;47(9):4612-4623. doi: 10.1093/nar/gkz165.

7.

High frequency of empty sella, with gender differences, in the early neuroradiology evaluation of patients with traumatic brain injury. A prospective study.

Fama' F, Vita R, Sindoni A, Vinci SL, Giorgianni G, Grasso L, Gioffre'-Florio M, Benvenga S.

J Clin Transl Endocrinol. 2018 Dec 31;15:54-61. doi: 10.1016/j.jcte.2018.12.008. eCollection 2019 Mar.

8.

MORAb-202, an Antibody-Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity.

Cheng X, Li J, Tanaka K, Majumder U, Milinichik AZ, Verdi AC, Maddage CJ, Rybinski KA, Fernando S, Fernando D, Kuc M, Furuuchi K, Fang F, Uenaka T, Grasso L, Albone EF.

Mol Cancer Ther. 2018 Dec;17(12):2665-2675. doi: 10.1158/1535-7163.MCT-17-1215. Epub 2018 Sep 27.

PMID:
30262588
9.

Tumor-shed antigen CA125 blocks complement-mediated killing via suppression of C1q-antibody binding.

Kline JB, Fernando S, Ross EN, Grasso L, Nicolaides NC.

Eur J Immunol. 2018 Nov;48(11):1872-1882. doi: 10.1002/eji.201847707. Epub 2018 Oct 19.

10.

Effect of combined treatment with a pan-PI3K inhibitor or an isoform-specific PI3K inhibitor and everolimus on cell proliferation in GH-secreting pituitary tumour in an experimental setting.

Pivonello C, Patalano R, Solari D, Auriemma RS, Frio F, Vitulli F, Grasso LFS, Di Cera M, De Martino MC, Cavallo LM, Cappabianca P, Colao A, Pivonello R.

Endocrine. 2018 Dec;62(3):663-680. doi: 10.1007/s12020-018-1677-2. Epub 2018 Jul 31.

PMID:
30066286
11.

Destiny of Failed Adjustable Gastric Bandings: Do All the Patients Need Further Bariatric Surgery?

Genzone A, Ferguglia A, Ambrazevicius M, Toppino M, Grasso L, Allaix ME, Morino M.

Obes Surg. 2018 Nov;28(11):3380-3385. doi: 10.1007/s11695-018-3373-y.

PMID:
29978440
12.

Farletuzumab, a monoclonal antibody directed against folate receptor alpha, shows no evidence of teratogenicity in cynomolgus monkeys.

Moriyama T, Kakiuchi D, Grasso L, Hutto DL, Fernando D, Schweizer C.

Reprod Toxicol. 2018 Aug;79:89-95. doi: 10.1016/j.reprotox.2018.06.007. Epub 2018 Jun 19.

PMID:
29928988
13.

Circulating thyrotropin is upregulated by estradiol.

Benvenga S, Di Bari F, Granese R, Borrielli I, Giorgianni G, Grasso L, Le Donne M, Vita R, Antonelli A.

J Clin Transl Endocrinol. 2018 Feb 13;11:11-17. doi: 10.1016/j.jcte.2018.02.002. eCollection 2018 Mar.

14.

Tumor-Shed Antigen Affects Antibody Tumor Targeting: Comparison of Two 89Zr-Labeled Antibodies Directed against Shed or Nonshed Antigens.

Lee JH, Kim H, Yao Z, Szajek LP, Grasso L, Kim I, Paik CH.

Contrast Media Mol Imaging. 2018 Mar 12;2018:2461257. doi: 10.1155/2018/2461257. eCollection 2018.

15.

CA125 suppresses amatuximab immune-effector function and elevated serum levels are associated with reduced clinical response in first line mesothelioma patients.

Nicolaides NC, Schweizer C, Somers EB, Wang W, Fernando S, Ross EN, Grasso L, Hassan R, Kline JB.

Cancer Biol Ther. 2018 Jul 3;19(7):622-630. doi: 10.1080/15384047.2018.1449614. Epub 2018 Apr 25.

16.

Prion-like protein aggregates exploit the RHO GTPase to cofilin-1 signaling pathway to enter cells.

Zhong Z, Grasso L, Sibilla C, Stevens TJ, Barry N, Bertolotti A.

EMBO J. 2018 Mar 15;37(6). pii: e97822. doi: 10.15252/embj.201797822. Epub 2018 Mar 1.

17.

FCGR2A and FCGR3A Genotypes Correlate with Farletuzumab Response in Patients with First-Relapsed Ovarian Cancer Exhibiting Low CA125.

Wang W, Somers EB, Ross EN, Kline JB, O'Shannessy DJ, Schweizer C, Weil S, Grasso L, Nicolaides NC.

Cytogenet Genome Res. 2017;152(4):169-179. doi: 10.1159/000481213. Epub 2017 Oct 18.

PMID:
29041009
18.

Application of 3D tumoroid systems to define immune and cytotoxic therapeutic responses based on tumoroid and tissue slice culture molecular signatures.

Finnberg NK, Gokare P, Lev A, Grivennikov SI, MacFarlane AW 4th, Campbell KS, Winters RM, Kaputa K, Farma JM, Abbas AE, Grasso L, Nicolaides NC, El-Deiry WS.

Oncotarget. 2017 Aug 5;8(40):66747-66757. doi: 10.18632/oncotarget.19965. eCollection 2017 Sep 15.

19.

Tumor antigen CA125 suppresses antibody-dependent cellular cytotoxicity (ADCC) via direct antibody binding and suppressed Fc-γ receptor engagement.

Kline JB, Kennedy RP, Albone E, Chao Q, Fernando S, McDonough JM, Rybinski K, Wang W, Somers EB, Schweizer C, Grasso L, Nicolaides NC.

Oncotarget. 2017 Jul 7;8(32):52045-52060. doi: 10.18632/oncotarget.19090. eCollection 2017 Aug 8.

20.

Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging.

Hekman MCH, Boerman OC, Bos DL, Massuger LFAG, Weil S, Grasso L, Rybinski KA, Oosterwijk E, Mulders PFA, Rijpkema M.

Mol Pharm. 2017 Oct 2;14(10):3457-3463. doi: 10.1021/acs.molpharmaceut.7b00464. Epub 2017 Aug 30.

21.

Expression, Biochemistry, and Stabilization with Camel Antibodies of Membrane Proteins: Case Study of the Mouse 5-HT3 Receptor.

Hassaïne G, Deluz C, Grasso L, Wyss R, Hovius R, Stahlberg H, Tomizaki T, Desmyter A, Moreau C, Peclinovska L, Minniberger S, Mebarki L, Li XD, Vogel H, Nury H.

Methods Mol Biol. 2017;1635:139-168. doi: 10.1007/978-1-4939-7151-0_8.

PMID:
28755368
22.

Engineering humanized antibody framework sequences for optimal site-specific conjugation of cytotoxins.

Spidel JL, Albone EF, Cheng X, Vaessen B, Jacob S, Milinichik AZ, Verdi A, Kline JB, Grasso L.

MAbs. 2017 Aug/Sep;9(6):907-915. doi: 10.1080/19420862.2017.1330734. Epub 2017 May 25.

23.

Correlation of FCGRT genomic structure with serum immunoglobulin, albumin and farletuzumab pharmacokinetics in patients with first relapsed ovarian cancer.

O'Shannessy DJ, Bendas K, Schweizer C, Wang W, Albone E, Somers EB, Weil S, Meredith RK, Wustner J, Grasso L, Landers M, Nicolaides NC.

Genomics. 2017 Jul;109(3-4):251-257. doi: 10.1016/j.ygeno.2017.04.006. Epub 2017 Apr 25.

24.

Generation of therapeutic immunoconjugates via Residue-Specific Conjugation Technology (RESPECT) utilizing a native cysteine in the light chain framework of Oryctolagus cuniculus.

Albone EF, Spidel JL, Cheng X, Park YC, Jacob S, Milinichik AZ, Vaessen B, Butler J, Kline JB, Grasso L.

Cancer Biol Ther. 2017 May 4;18(5):347-357. doi: 10.1080/15384047.2017.1312232. Epub 2017 Apr 10.

25.

Erratum: Global transcriptomic responses of Escherichia coli K-12 to volatile organic compounds.

Yung PY, Lo Grasso L, Mohidin AF, Acerbi E, Hinks J, Seviour T, Marsili E, Lauro FM.

Sci Rep. 2017 Apr 6;7:33108. doi: 10.1038/srep33108. No abstract available.

26.

The effects of modified versus unmodified wheat gluten administration in patients with celiac disease.

Marino M, Casale R, Borghini R, Di Nardi S, Donato G, Angeloni A, Moscaritolo S, Grasso L, Mazzarella G, Di Tola M, Rossi M, Picarelli A.

Int Immunopharmacol. 2017 Jun;47:1-8. doi: 10.1016/j.intimp.2017.03.012. Epub 2017 Mar 23.

PMID:
28343108
27.

Poly(carboxylic acid)-Cyclodextrin/Anionic Porphyrin Finished Fabrics as Photosensitizer Releasers for Antimicrobial Photodynamic Therapy.

Castriciano MA, Zagami R, Casaletto MP, Martel B, Trapani M, Romeo A, Villari V, Sciortino MT, Grasso L, Guglielmino S, Scolaro LM, Mazzaglia A.

Biomacromolecules. 2017 Apr 10;18(4):1134-1144. doi: 10.1021/acs.biomac.6b01752. Epub 2017 Mar 20.

PMID:
28257182
28.

Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities.

Pivonello R, Auriemma RS, Grasso LF, Pivonello C, Simeoli C, Patalano R, Galdiero M, Colao A.

Pituitary. 2017 Feb;20(1):46-62. doi: 10.1007/s11102-017-0797-7. Review.

PMID:
28224405
29.

Somatostatin analogs, cabergoline and pegvisomant: comparing the efficacy of medical treatment for acromegaly.

Grasso LFS, Auriemma RS, Pivonello R, Colao A.

Expert Rev Endocrinol Metab. 2017 Jan;12(1):73-85. doi: 10.1080/17446651.2016.1222899. Epub 2016 Sep 7.

PMID:
30058878
30.

Perineal stapled prolapse resection for full-thickness external rectal prolapse: a multicentre prospective study.

Mistrangelo M, Tonello P, Brachet Contul R, Arnone G, Passera R, Grasso L, Rapetti L, Borroni R, Pozzo M, Roveroni M, Morino M, Perinotti R.

Colorectal Dis. 2016 Nov;18(11):1094-1100. doi: 10.1111/codi.13328.

PMID:
26969880
31.

Rapid high-throughput cloning and stable expression of antibodies in HEK293 cells.

Spidel JL, Vaessen B, Chan YY, Grasso L, Kline JB.

J Immunol Methods. 2016 Dec;439:50-58. doi: 10.1016/j.jim.2016.09.007. Epub 2016 Sep 24.

32.

mRNA Cap Methylation in Pluripotency and Differentiation.

Grasso L, Suska O, Davidson L, Gonatopoulos-Pournatzis T, Williamson R, Wasmus L, Wiedlich S, Peggie M, Stavridis MP, Cowling VH.

Cell Rep. 2016 Aug 2;16(5):1352-1365. doi: 10.1016/j.celrep.2016.06.089. Epub 2016 Jul 21.

33.

Effects of long-term combined treatment with somatostatin analogues and pegvisomant on cardiac structure and performance in acromegaly.

Auriemma RS, Grasso LF, Galdiero M, Galderisi M, Pivonello C, Simeoli C, De Martino MC, Ferrigno R, Negri M, de Angelis C, Pivonello R, Colao A.

Endocrine. 2017 Mar;55(3):872-884. doi: 10.1007/s12020-016-0995-5. Epub 2016 Jun 13.

PMID:
27295183
34.

Sub-toxic concentrations of volatile organic compounds inhibit extracellular respiration of Escherichia coli cells grown in anodic bioelectrochemical systems.

Santoro C, Mohidin AF, Grasso LL, Seviour T, Palanisamy K, Hinks J, Lauro FM, Marsili E.

Bioelectrochemistry. 2016 Dec;112:173-7. doi: 10.1016/j.bioelechem.2016.02.003. Epub 2016 Feb 21.

PMID:
26947021
35.

The safety of treatments for prolactinomas.

Auriemma RS, Grasso LF, Pivonello R, Colao A.

Expert Opin Drug Saf. 2016;15(4):503-12. doi: 10.1517/14740338.2016.1151493. Epub 2016 Mar 7. Review.

PMID:
26855238
36.

Global transcriptomic responses of Escherichia coli K-12 to volatile organic compounds.

Yung PY, Grasso LL, Mohidin AF, Acerbi E, Hinks J, Seviour T, Marsili E, Lauro FM.

Sci Rep. 2016 Jan 28;6:19899. doi: 10.1038/srep19899. Erratum in: Sci Rep. 2017 Apr 06;7:33108.

37.

The Structure of the Mouse Serotonin 5-HT3 Receptor in Lipid Vesicles.

Kudryashev M, Castaño-Díez D, Deluz C, Hassaine G, Grasso L, Graf-Meyer A, Vogel H, Stahlberg H.

Structure. 2016 Jan 5;24(1):165-170. doi: 10.1016/j.str.2015.11.004. Epub 2015 Dec 24.

38.

Inguinal Hernia: Lap vs Open.

Vassiliadis A, Zanoni A, Di Leo A, Zanella S, Lauro E, Moscatelli P, Ricci F, Huang H, Wada N, Furukawa T, Kitagawa Y, Hirukawa H, Takesue Y, Saito K, Sato H, Tada T, Choua O, Fu XJ, Yao QY, Yang S, Wang MG, Zhu YL, Cao JX, Shen YM, Togbe JO, Gbessi DG, Dossou FM, Iawani I, Cijan V, Gencic M, Scepanovic M, Bojovic P, Brankovic M, Agresta F, Verza LA, Prando D, Roveran MA, Azabdaftari A, Rubinato L, Vacca U, Lubrano T, Vidotto C, Falcone A, Grasso L, Ghiglione F, Morino M, Nácul M, Cavazzola L, Loureiro M, Bonin E, Ferreira P, Misra MC, Bansal VK, Subodh K, Krisha A, Bansal D, Ray S, Rajeshwari S, Wang P, Jia Z, Zhang FJ, Yan JJ, Zhu YH, Jiang K, Altinli E, Eroglu E, Sertel HI, Hizli F, Jacob B, Bresnaham E, Reiner M, Bates A.

Hernia. 2015 Apr;19 Suppl 1:S57-62. doi: 10.1007/BF03355327. No abstract available.

PMID:
26518862
39.

Topic: Inguinal Hernia - Primary inguinal hernia, state of the art in the different socio economic reality.

Lubrano T, Vidotto C, Falcone A, Grasso L, G F, Morino M, Techapongsatorn S, Tansawet A, Lerdsirisopon S, Kasetsermwiriya W, Srimontayamas S, Loapeamthong CU, Teawprasert P, Takehara H, Nishihara M, Kuniyoshi F, Miyahira T, Hanashiro N, Takushi Y, Aka H, Nakagawa H, Shiraishi M, Okushima N, Soler M, Oyama R, Chihara N, Suzuki H, Watanabe M, Nakata R, Uchida E, Mitura K, Koziel S, Pasierbek M, Maietta P, Iannace C, Lee H, Cho H, Jovanovic S, Pejcic V, Trenkic M, Filipovic N, Pavlovic A, Jovanovc B, Hemberg A, Nordin P, Holmberg H, De Rosa A, Meyer A, Seabra AP, Sorge A, Hack J, Soares LA, Chalub SR, Malcher R, Kingsnorth A, Dabic D, Maric B, Perunicic V, Kocaay AF, Eker T, Celik SU, Akyol C, Cakmak A, Contino E, Molinari P, Lanza C, Binda M, Livraghi L, Farassino L, Cocozza E, Crespi A, Ambrosoli A, Zhao Y, Li JW, Zheng MH.

Hernia. 2015 Apr;19 Suppl 1:S275-80. doi: 10.1007/BF03355371. No abstract available.

PMID:
26518823
40.

Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature.

Rybinski K, Imtiyaz HZ, Mittica B, Drozdowski B, Fulmer J, Furuuchi K, Fernando S, Henry M, Chao Q, Kline B, Albone E, Wustner J, Lin J, Nicolaides NC, Grasso L, Zhou Y.

Oncotarget. 2015 Sep 22;6(28):25429-40. doi: 10.18632/oncotarget.4559.

41.

Tumor and organ uptake of (64)Cu-labeled MORAb-009 (amatuximab), an anti-mesothelin antibody, by PET imaging and biodistribution studies.

Lee JH, Kim H, Yao Z, Lee SJ, Szajek LP, Grasso L, Pastan I, Paik CH.

Nucl Med Biol. 2015 Nov;42(11):880-6. doi: 10.1016/j.nucmedbio.2015.07.008. Epub 2015 Jul 29.

42.

Adverse events associated with somatostatin analogs in acromegaly.

Grasso LF, Auriemma RS, Pivonello R, Colao A.

Expert Opin Drug Saf. 2015 Aug;14(8):1213-26. doi: 10.1517/14740338.2015.1059817. Review.

PMID:
26184380
43.

Thalassaemia major and infectious risk: High Mobility Group Box-1 represents a novel diagnostic and prognostic biomarker.

Chirico V, Lacquaniti A, Piraino B, Cutrupi M, Cuppari C, Grasso L, Rigoli L, David A, Arrigo T, Salpietro C.

Br J Haematol. 2015 Oct;171(1):130-6. doi: 10.1111/bjh.13530. Epub 2015 Jun 8.

PMID:
26058743
44.

Increase in the Level of Proinflammatory Cytokine HMGB1 in Nasal Fluids of Patients With Rhinitis and its Sequestration by Glycyrrhizin Induces Eosinophil Cell Death.

Cavone L, Cuppari C, Manti S, Grasso L, Arrigo T, Calamai L, Salpietro C, Chiarugi A.

Clin Exp Otorhinolaryngol. 2015 Jun;8(2):123-8. doi: 10.3342/ceo.2015.8.2.123. Epub 2015 May 13.

45.

Two Master Switch Regulators Trigger A40926 Biosynthesis in Nonomuraea sp. Strain ATCC 39727.

Lo Grasso L, Maffioli S, Sosio M, Bibb M, Puglia AM, Alduina R.

J Bacteriol. 2015 Aug 1;197(15):2536-44. doi: 10.1128/JB.00262-15. Epub 2015 May 18.

46.

Molecular screening of cancer-derived exosomes by surface plasmon resonance spectroscopy.

Grasso L, Wyss R, Weidenauer L, Thampi A, Demurtas D, Prudent M, Lion N, Vogel H.

Anal Bioanal Chem. 2015 Jul;407(18):5425-32. doi: 10.1007/s00216-015-8711-5. Epub 2015 Apr 30.

47.

Systemic effects of locally injected platelet rich plasma in a rat model: an analysis on muscle and bloodstream.

Borrione P, Grasso L, Racca S, Abbadessa G, Carriero V, Fagnani F, Quaranta F, Pigozzi F.

J Biol Regul Homeost Agents. 2015 Jan-Mar;29(1):251-8.

48.

Evaluation of the retinal nerve fibre layer and ganglion cell complex thickness in pituitary macroadenomas without optic chiasmal compression.

Cennamo G, Auriemma RS, Cardone D, Grasso LF, Velotti N, Simeoli C, Di Somma C, Pivonello R, Colao A, de Crecchio G.

Eye (Lond). 2015 Jun;29(6):797-802. doi: 10.1038/eye.2015.35. Epub 2015 Mar 27.

49.

Acute pulmonary exacerbation and lung function decline in patients with cystic fibrosis: high-mobility group box 1 (HMGB1) between inflammation and infection.

Chirico V, Lacquaniti A, Leonardi S, Grasso L, Rotolo N, Romano C, Di Dio G, Lionetti E, David A, Arrigo T, Salpietro C, La Rosa M.

Clin Microbiol Infect. 2015 Apr;21(4):368.e1-9. doi: 10.1016/j.cmi.2014.11.004. Epub 2014 Nov 15.

50.

The organizer in evolution-gastrulation and organizer gene expression highlight the importance of Brachyury during development of the coral, Acropora millepora.

Hayward DC, Grasso LC, Saint R, Miller DJ, Ball EE.

Dev Biol. 2015 Mar 15;399(2):337-47. doi: 10.1016/j.ydbio.2015.01.006. Epub 2015 Jan 16.

Supplemental Content

Loading ...
Support Center